This application, created by the WMA and the New Jersey Medical School Global Tuberculosis Institute, gives physicians the flexibility to access the course material at any time, even when they are discussing treatment options with their patients. The application was developed in collaboration with the World Health Organization with financial support from the Eli Lilly MDR-TB partnership...
Favorite
2013
Based on The Union's 93-years of working in the field, the new guide tackles the challenges of fulfilling each patient's potential for cure from both the clinician's and the programme manager's perspective.
Favorite
International Agencies
Managers and Supervisors
2013
This interim guidance provides advice on the inclusion of bedaquiline in the combination therapy of MDR-TB in accordance with the existing WHO Guidelines for the Programmatic Management of Drug-resistant TB (2011 Update).
Favorite
2013
This report gives a first-ever snapshot of the burden and threats posed by the antibiotic-resistant germs having the most impact on human health.
Favorite
Policy Makers
2013
This is the eighteenth global report on tuberculosis (TB) published by WHO in a series that started in 1997. It provides a comprehensive and up-to-date assessment of the TB epidemic and progress in implementing and ?nancing TB prevention, care and control at global, regional and country levels using data reported by 197 countries and territories that account for over 99% of the world’s TB cases.
Favorite
International Agencies
Managers and Supervisors
Policy Makers
2013
This information sheet discusses multidrug-resistant TB (MDR TB), a strain of TB that is resistant to at least two of the best anti-TB drugs, isoniazid and rifampicin. It describes TB disease, MDR TB, extensively drug resistant TB (XDR TB), TB transmission, how drug resistance happens, and who is at risk for getting MDR TB...
Favorite
2012
This fact sheet provides an overview of multidrug-resistant tuberculosis (MDR TB) and extensively drug-resistant tuberculosis (XDR TB). This fact sheet covers definitions, symptoms, treatment, transmission, and prevention.
Favorite
2012
This fact sheet provides an overview of Tuberculosis and multidrug-resistant TB and extensively drug resistant TB. The fact sheet covers definitions, how TB is spread, symptoms, risk factors, prevention and what to do before traveling internationally.
Favorite
2012
In January 2012, members of the Sentinel Project on Pediatric Drug-Resistant Tuberculosis reached out to organizations treating children with DR-TB in diverse settings and asked them to submit short stories and photos. These stories pay tribute to the thousands of children who, with the help of dedicated health care providers and family members, have fought and overcome DR-TB.
Favorite
2012
This Course is intended as an introduction to multidrug-resistant tuberculosis (MDR-TB) management, and is aimed at medical practitioners involved in the detection, management and treatment of MDR-TB patients, under the guiding principles of the World Health Organization's Stop TB Strategy. The Course aims to facilitate self-study by medical practitioners of contemporary, evidence-based standards for diagnosis and clinical management of MDR-TB in a variety of geographical, economic and social settings...
Favorite
2012
The MDR-TB Planning Toolkit is designed to help assist countries develop or strengthen a multidrug-resistant tuberculosis (MDR-TB) component within their national TB strategy or plan. Eight tools contain worksheets to assist the user through key planning steps. The toolkit is intended for countries, technical partners, international organizations, and donors.
Favorite
International Agencies
Policy Makers
2012
This is the seventeenth global report on tuberculosis (TB) published by WHO in a series that started in 1997. It provides a comprehensive and up-to-date assessment of the TB epidemic and progress in implementing and financing TB prevention, care and control at global, regional and country levels using data reported by 204 countries and territories that account for over 99% of the world’s TB cases.
Favorite
International Agencies
Managers and Supervisors
Policy Makers
2012
This infographic discusses the global impact of multidrug-resistant TB (MDR TB). Two patient stories are also included in the infographic.
Favorite
2012
This report highlights the issues surrounding high prices and poor supply of the drugs needed to treat drug-resistant tuberculosis (DR-TB). The report provides an overview of available drug-resistant TB medicines, including drug sources, quality status, and price.
Favorite
International Agencies
Policy Makers
2011
This document lists the essential research questions that will provide a common framework for various scientific disciplines to work concurrently and collaboratively towards better TB control and elimination.
Favorite
Policy Makers
2011
